Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Akero Therapeutics

AKRO

AKRO Akero Therapeutics NASDAQ
Add to watchlist
28.24
0.16 (+0.57 %)
At close : Jan 03, 16:00 ET
27.88
-0.36 (-1.27 %)
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    AKRO Chart
    See on advanced chart >
    • Volume 725.35k
    • Turnover 20.49M
    • P/E(TTM) --
    • Turnover % 1.24%
    • P/E(Static) --
    • Market Cap 1.97B
    • P/B 2.67
    • Shares 69.80M
    • 52 Week Range
      15.32
      37.00
    • Day Range
      27.86
      28.73

    About

    Akero Therapeutics, Inc. was incorporated in January 2017 under the laws of the State of Delaware. The company is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with...
    • Highlight
      A clinical-stage company that develops transformational treatments for serious metabolic diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/20/2019
    • Established Date
      Invalid Date
    • Full-time Employees
      56
    • Address
      601 Gateway Boulevard Suite 350 South San Francisco CA 94080
    • Tel
      1-650-4876488
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App